What is your surveillance protocol for patients with common variable immunodeficiency receiving chronic IVIG therapy?
Is there a target IgG level to aim for?
What should hematologists be aware of in monitoring these patients?
1 Answer
Mednet MemberInvited Expert
Allergy & Immunology · University Hospitals Cleveland Medical Center
Answered on · Updated on
No target IgG level per se- dose/interval should be titrated to clinical condition. In general, trough IgG on treatment should be higher than 500 mg/dL, or 500 mg/dL higher than baseline. Most patients will not be in optimal clinical condition (minimal fatigue, arthralgias, absence of chronic cough,...
Join for free or sign in to see the full answer